Evid Based Nurs 7:49 doi:10.1136/ebn.7.2.49
  • Treatment

Oestrogen plus progestogen did not prevent cardiovascular disease in postmenopausal women

Oestrogen plus progestogen v placebo in postmenopausal women*

Annualised percentage developing coronary heart disease (CHD)
Outcomes at mean 5.3 years Oestrogen plus progestogen Placebo Adjusted hazard ratio (95% CI)
*CI defined in glossary. Hazard ratio adjusted for the presence or absence of previous coronary revascularization and sequential monitoring.
†Not significant.
All CHD 0.39% 0.33% 1.24 (0.97 to 1.60)†
Non-fatal myocardial infarction (MI) 0.31% 0.25% 1.28 (0.96 to 1.70)†
Nonfatal MI (excluding silent MI) 0.31% 0.24% 1.30 (0.97 to 1.74)†
Death caused by CHD 0.08% 0.08% 1.10 (0.65 to 1.89)†

This Article

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article